Humacyte, Inc.
HUMA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$17,510 | -$37,658 | $39,139 | -$20,940 |
| Dep. & Amort. | $1,865 | $1,860 | $1,832 | -$322 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,461 | $0 | $2,487 | $1,694 |
| Change in WC | -$4,121 | -$1,398 | -$9,564 | -$2,812 |
| Other Non-Cash | -$6,599 | $10,783 | -$62,495 | -$4,197 |
| Operating Cash Flow | -$23,904 | -$26,413 | -$28,601 | -$26,577 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$49 | -$568 | -$228 | -$63 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$49 | -$568 | -$228 | -$63 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$743 | -$727 | -$687 | $1,666 |
| Stock Issued | $9,800 | $3,233 | $47,000 | $1,517 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$53,648 | -$340 | $426 | $47,823 |
| Financing Cash Flow | -$44,591 | $2,166 | $46,739 | $51,006 |
| Forex Effect | $0 | -$144 | $0 | $0 |
| Net Chg. in Cash | -$68,544 | -$24,959 | $17,910 | $24,366 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $88,385 | $62,991 | $95,290 | $70,924 |
| End Cash | $19,841 | $38,032 | $113,200 | $95,290 |
| Free Cash Flow | -$23,953 | -$26,981 | -$28,829 | -$26,640 |